Randomized, double blinded, active control comparative, multicenter-designed, phase IV clinical trial to evaluate the efficacy and safety of tacrolimus versus leflunomide as an additional medication in the patients with rheumatoid arthritis refractory to methotrexate

Trial Profile

Randomized, double blinded, active control comparative, multicenter-designed, phase IV clinical trial to evaluate the efficacy and safety of tacrolimus versus leflunomide as an additional medication in the patients with rheumatoid arthritis refractory to methotrexate

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 May 2017

At a glance

  • Drugs Tacrolimus (Primary) ; Leflunomide
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms Platinum-X
  • Most Recent Events

    • 03 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top